| |
Our main pages on this subject:
| 1. | Merck Frosst Canada - VIOXX® Information Center | | | In the case, Anthony Wayne Dedrick claimed he took VIOXX for approximately six months before his heart attack. " The jury determined that Merck & Co acted appropriately in the development and marketing of VIOXX and that VIOXX did not substantially contribute to Mr. Dedrick's heart attack, " said Phil Beck, of the law firm of Bartlit Beck, Merck & Co's lead trial lawyer in the case, Dedrick v. Merck & Co. " He had multiple risk factors for a heart attack including a family history of cardiac problems, heavy smoking for many years and he had high blood pressure, high cholesterol and diabetes, " Mr. Beck said.... | | | | 2. | Merck Frosst Canada - VIOXX® Information Center | | | The Mason case was specifically selected by the Plaintiffs ' Steering Committee for this trial. " The jury determined that Merck acted appropriately in the development and marketing of VIOXX and that VIOXX did not substantially contribute to Mr. Mason's heart attack, " said Phil Beck, of the law firm of Bartlit Beck, Merck's lead trial lawyer in the case, Mason v. Merck. " In addition, Mr. Mason's claims about his VIOXX use simply didn't hold up to scrutiny, " Beck said.... | | | | 3. | Merck Frosst Canada - VIOXX® Information Center | | | Kirkland, QC, Feb 17, 2006 - - Merck & Co, Inc today said it is pleased that a federal court jury in New Orleans returned a defense verdict in Plunkett v. Merck by rejecting a claim that short-term use of VIOXX played a role in the 2001 death of a Florida man.The jury's decision confirms that there is no medical or scientific evidence showing short-term use of VIOXX increases the risk of heart attack and contributed in any way to the unfortunate death of Richard Irvin, said Philip Beck, of the law firm of Bartlit Beck, Merck's lead trial lawyer in the case.. | | |
See the following 3 related subjects: |
